Feed NEOG
NE

Neogen Corporation

NEOG · NASDAQ

$12.55 +2.03% (+$0.25)
1M +8.47%
Market Cap $2.74B
P/E Ratio -
Div. Yield -
ROE 0.37%
Piotroski F-Score Moderate
6/9
Valuation
32 /100
Expensive
EV/EBITDA 19.44x
P/FCF 85.79x
P/S 3.14x
Growth
100 /100
Growing
Rev. growth 19.28%
Book val. growth 32.65%
EPS growth N/A
Profitability
28 /100
Weak
Gross margin 46.93%
FCF margin 3.67%
Net margin 0.91%
Quality
4 /100
Poor
ROIC 0.60%
Asset turnover 0.26x
ROE 0.37%
Debt
57 /100
Moderate
Debt/Equity 0.38x
Net debt/EBITDA 3.53x
Current ratio 3.82x
Stability
12 /100
Unstable
Beta 1.76x
Profitable years 0
Rev. volatility 30.70%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about NEOG
Online

About the company

Neogen Corporation is a global biotechnology company specializing in providing solutions for detecting and preventing risks in food, feed, and healthcare. The company develops and commercializes a wide range of testing products that help protect public health, including tests for detecting pathogens, allergens, mycotoxins, and other contaminants in food. Neogen also provides products for veterinary medicine and pharmaceutical manufacturing, making it a key player in food safety and health risk management.

Sector

Healthcare

Industry

Medical - Devices

CEO

Mikhael Nassif

Employees

2,636

Headquarters

Lansing

Upcoming events

06 OCT

Earnings

Upcoming earnings report

19d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.